A Minimally Invasive Approach for Cardiac Electrophysiology Studies in Mice

Min Zi; Sabu Abraham; Alicia D'souza; David Hutchings; Sukhpal Prehar; Xin Wang; Elizabeth J Cartwright

doi:10.53941/ijddp.0201006

Abstract

Atrial fibrillation and ventricular tachycardia are commonly seen in clinic. Different approaches have been developed to investigate underlying mechanisms. Transvenous approach (TA) is widely used for studies but has several drawbacks. We therefore developed a novel minimally invasive approach (MIA) for mechanistic studies. Study included 27 male C57BL/6J mice, 19 for MIA and 8 for TA. Under general anaesthesia, ECG was recorded. A key hole was made on the right first intercostal space by separating the intercostal muscles, followed by the exposure of the superior vena cava and the top of the atrium. An EPR-800 catheter was inserted vertically, perpendicular to the chest, for atrial pacing and flatly over the ventricles for ventricular pacing. Burst S1–S1 and decremental S1–S2 pacing protocols were performed to evaluate SA recovery time (SNRT), the atrioventricular node effective refractory period (AVN-ERP), Wenckebach period, ventricular ERP, and arrhythmia susceptibility. MIA was successfully performed in all 19 mice without any complications. One mouse died during TA due to venous rupture. Compared MIA with TA, surgical time were significantly shorter (P<0.0001). Wenckebach period was shorter as well (P<0.05). No difference was found in baseline sinus cycle length, SNRT, correct SNRT, AVN-ERP, ventricular ERP, and arrhythmia susceptibility (all P>0.05). The novel MIA outplays TA by providing similar outcomes of PES but consuming less time, demanding less surgical expertise, and reducing the potential of surgical complications. Given the minimal tissue injury, it also provides great potential as a recovery procedure for longitudinal study.

References

1.
(NICE) NIfHaCE: Atrial fibrillation: How common is it? https://cksniceorguk/topics/atrial-fibrillation/background-information/prevalence/2022.
2.
Colilla S.; Crow A.; Petkun W.; et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am. J. Cardiol., 2013, 112(8): 1142‒1147.
3.
Go A.S.; Hylek E.M.; Phillips K.A.; et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001, 285(18): 2370‒2375.
4.
January C.T.; Wann L.S.; Calkins H.; et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol., 2019, 74(1):104‒132.
5.
January C.T.; Wann L.S.; Alpert J.S.; et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol., 2014, 64(21):e1‒76.
6.
Wyse D.G.; Love J.C.; Yao Q.; et al. Atrial fibrillation: a risk factor for increased mortality——an AVID registry analysis. J. Interv. Card. Electrophysiol., 2001, 5(3): 267‒273.
7.
Anter E.; Jessup M.; Callans D.J. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation, 2009, 119(18): 2516‒2525.
8.
Savelieva I.; Camm A.J. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J. Interv. Card. Electrophysiol., 2000, 4(2): 369‒382.
9.
Bernardi J.; Aromolaran K.A.; Zhu H.; et al. Circadian mechanisms: cardiac ion channel remodeling and arrhythmias. Front. Physiol., 2021, 11: 611860.
10.
Fomin D.; Chmieliauskas S.; Laima S.; et al. Sudden cardiac death in patients with coronary heart disease and antemortem alcohol intake: a STROBE - compliant retrospective study. Medicine, 2022, 101(45): e31396.
11.
Koivunen M.; Tynkkynen J.; Oksala N.; et al. Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction. Am. Heart J., 2023, 257: 9‒19.
12.
Safabakhsh S.; Al-Shaheen A.; Swiggum E.; et al. Arrhythmic sudden cardiac death in heart failure with preserved ejection fraction: mechanisms, genetics, and future directions. CJC Open, 2022, 4(11): 959‒969.
13.
Berul C.I.; Aronovitz M.J.; Wang P.J.; et al. In vivo cardiac electrophysiology studies in the mouse. Circulation, 1996, 94(10): 2641‒2648.
14.
VanderBrink B.A.; Sellitto C.; Saba S.; et al. Connexin40-deficient mice exhibit atrioventricular nodal and infra-Hisian conduction abnormalities. J. Cardiovasc. Electrophysiol., 2000, 11(11): 1270‒1276.
15.
VanderBrink B.A.; Link M.S.; Aronovitz M.J.; et al. Assessment of atrioventricular nodal physiology in the mouse. J. Interventional Card. Electrophysiol., 1999, 3(3): 207‒212.
16.
Schrickel J.W.; Bielik H.; Yang A.; et al. Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res. Cardiol., 2002, 97(6): 452‒460.
17.
Gutstein D.E.; Danik S.B.; Sereysky J.B.; et al. Subdiaphragmatic murine electrophysiological studies: sequential determination of ventricular refractoriness and arrhythmia induction. Am. J. Physiol.: Heart Circ. Physiol., 2003, 285(3): H1091‒H1096.
18.
Kaese S.; Verheule S. Cardiac electrophysiology in mice: a matter of size. Front. Physiol., 2012, 3: 345.
19.
Etzion Y.; Mor M.; Shalev A.; et al. New insights into the atrial electrophysiology of rodents using a novel modality: the miniature-bipolar hook electrode. Am. J. Physiol.: Heart Circ. Physiol., 2008, 295(4): H1460‒H1469.
20.
Ripplinger C.M.; Glukhov A.V.; Kay M.W.; et al. Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals. Am. J. Physiol.: Heart Circ. Physiol., 2022, 323(6): H1137‒H1166.
21.
Favere K.; Van Fraeyenhove J.; Jacobs G.; et al. Cardiac electrophysiology studies in mice via the transjugular route: a comprehensive practical guide. Am. J. Physiol.: Heart Circ. Physiol. 2022, 323(4): H763‒H773.
22.
Hennis K.; Rötzer R.D.; Rilling J.; et al. In vivo and ex vivo electrophysiological study of the mouse heart to characterize the cardiac conduction system, including atrial and ventricular vulnerability. Nat. Protoc., 2022, 17(5): 1189‒1222.
23.
Atkinson W.; Forghani R.; Wojtkiewicz G.R.; et al. Ligation of the jugular veins does not result in brain inflammation or demyelination in mice. PLoS One, 2012, 7(3): e33671.
24.
Chatzidou S.; Kontogiannis C.; Georgiopoulos G.; et al. Wenckebach cycle length: a novel predictor for AV block in AVNRT patients treated with ablation. Pacing Clin. Electrophysiol., 2021, 44(9): 1497‒1503.
25.
Li N.; Wehrens X.H.T. Programmed electrical stimulation in mice. J. Visualized Exp., 2010, (39): 1730.
26.
Boukens B.J.; Rivaud M.R.; Rentschler S.; et al. Misinterpretation of the mouse ECG: ‘musing the waves of Mus musculus’. J. Physiol., 2014, 592(21): 4613‒4626.
27.
Chowdhury S.K.; Liu W.; Zi M.; et al. Stress-activated kinase mitogen-activated kinase kinase-7 governs epigenetics of cardiac repolarization for arrhythmia prevention. Circulation, 2017, 135(7): 683‒699.
28.
Maguire C.T.; Wakimoto H.; Patel V.V.; et al. Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies. Physiol. Genomics, 2003, 15(1): 84‒91.
29.
Clasen L.; Eickholt C.; Angendohr S.; et al. A modified approach for programmed electrical stimulation in mice: inducibility of ventricular arrhythmias. PLoS One, 2018, 13(8): e0201910.
30.
Wakimoto H.; Maguire C.T.; Kovoor P.; et al. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc. Res., 2001, 50(3): 463‒473.
31.
Kong N.W.; Upadhyay G.A. Cardiac resynchronization considerations in left bundle branch block. Front. Physiol., 2022, 13: 962042.

Scilight Press

Author Information

Abstract

Keywords

References

About Scilight

Journals

Publishing Policies

Contact Us